Current Report Filing (8-k)
2021年9月22日 - 5:12AM
Edgar (US Regulatory)
0001307624
false
0001307624
2021-09-15
2021-09-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): September 15, 2021
______________
HEALTHTECH SOLUTIONS,
INC./UT
(Exact name of registrant
as specified in its charter)
______________
Utah
|
0-51012
|
84-2528660
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
181 Dante Avenue,
Tuckahoe, New York 10707
(Address of Principal
Executive Office) (Zip Code)
844-926-3399
(Registrant’s telephone
number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
|
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
ITEM 5.02
|
ELECTION OF DIRECTOR
|
On September 15, 2021 Edward Swanson resigned from
his position as the Registrant's Chief Executive Officer, and Bradley Mathis resigned from his position as the Registrant's Chief Operating
Officer. On September 16, 2021, Ryan Salomone resigned from his position as a member of the Registrant's Board of Directors.
On September
21, 2021, the Board of Directors elected Paul Mann, a member of the Board, to serve as the Chairman of the Board.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
Healthtech Solutions, Inc.
|
|
|
|
Date: September 21, 2021
|
By:
|
/s/ Manuel E. Iglesias
Manuel E. Iglesias, President
|
HealthTech Solutions (CE) (USOTC:HLTT)
過去 株価チャート
から 10 2024 まで 11 2024
HealthTech Solutions (CE) (USOTC:HLTT)
過去 株価チャート
から 11 2023 まで 11 2024